Trametinib alleviates lipopolysaccharide-induced acute kidney injury by inhibiting macrophage polarization through the PI3K/Akt pathway
- 30 January 2025
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 89, 102183
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- FAM76B regulates PI3K/Akt/NF-κB-mediated M1 macrophage polarization by influencing the stability of PIK3CD mRNACellular and Molecular Life Sciences, 2024
- Characterization of Risk Prediction Models for Acute Kidney InjuryJAMA Network Open, 2023
- Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitorsCell Reports, 2021
- The IL-17 Family of Cytokines in Health and DiseaseImmunity, 2019
- Rictor deficiency in dendritic cells exacerbates acute kidney injuryKidney International, 2018
- Acute kidney injury in sepsisIntensive Care Medicine, 2017
- Origin and Functions of Tissue MacrophagesImmunity, 2014
- The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAsImmunity, 2009
- A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast CancerCancer Cell, 2007
- Inflammation and IGF‐I activate the Akt pathway in breast cancerInternational Journal of Cancer, 2006